Fig. 3From: Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerESRP2 and common chromosomal deletions. For statistical analysis contingency tables and the chi2-test were performedBack to article page